V
VERV
Verve Therapeutics, Inc.
This stock has been delisted.
News
Press Releases
Financial Reports
Profile
Reuters·08/07/2025 10:46
Eli Lilly Reports Q2 2025 Revenue Surge of 38% to $15.56 Billion, EPS Up 92% to $6.29
Dow Jones·07/25/2025 21:08
*News On Verve Therapeutics Inc. (VERV) Now Under LLY
TipRanks·07/25/2025 20:51
Verve Therapeutics Announces Merger and Nasdaq Delisting
Reuters·07/25/2025 20:17
Verve Therapeutics Inc. Announces Delisting from Nasdaq Following Merger Completion
TipRanks·07/25/2025 12:56
Eli Lilly completes acquisition of Verve Therapeutics
Dow Jones·07/24/2025 12:02
*Eli Lilly Expects to Complete Verve Acquisition on July 25 >LLY VERV
Dow Jones·07/24/2025 12:01
*Eli Lilly: About 55.7% of Verve Shares Tendered >LLY VERV
Reuters·07/24/2025 12:00
ELI LILLY AND CO - TENDER OFFER FOR VERVE SHARES AT $10.50 PER SHARE
Dow Jones·07/24/2025 12:00
*Lilly and Verve Announce Expiration of Verve Tender Offer
Dow Jones·07/24/2025 12:00
Press Release: Lilly and Verve announce expiration of Verve tender offer
NASDAQ·07/23/2025 19:26
Noteworthy Wednesday Option Activity: WEN, HAS, VERV
TipRanks·07/15/2025 10:45
Verve Therapeutics Announces Retention Bonus Program for Executives
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.